Russell J. Cox - Jun 9, 2022 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
Director
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Stock symbol
GOSS
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
7/15/2022, 05:06 PM
Previous filing
Jun 9, 2022
Next filing
Jun 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GOSS Stock Option (Right to Buy) Award $0 +30K $0.00 30K Jun 9, 2022 Common Stock 30K $7.02 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award made pursuant to Non-Employee Director Compensation Program.
F2 The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer'sstockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.